Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on August 20, 2026

Aug. 20, 2026

14 Custom Awnings Installed for Heartland Dental's 1,900+ Practice Network in Dallas

Indeterminate EIN Presswire

Aug. 20, 2026

Hydrate IV Bar Frisco Named 'The Face of IV Therapy 2026' by Faces of Frisco

Indeterminate EIN Presswire

Aug. 20, 2026

Comfort Keepers of Austin Shares Questions for Home Care Families

Indeterminate EIN Presswire

Aug. 20, 2026

San Antonio Families Turn to Local In-Home Care Agencies for Trusted Support

Indeterminate EIN Presswire

Aug. 20, 2026

HR for Health’s Dental Leadership Summit Brings the Industry Together for Peer-to-Peer Learning and Real-World Strategy

Indeterminate EIN Presswire

Aug. 20, 2026

Beaumont Dermatologist Launches Redesigned Website with Cosmetic Focus

Indeterminate EIN Presswire

Aug. 20, 2026

Keystone Substance Abuse Services Rebrands as Keystone Behavioral Health, Expanding Behavioral Health Services in York County

Indeterminate GlobeNewswire

Aug. 20, 2026

Keeping a promise: Ballad Health breaks ground on new Unicoi County Hospital

Indeterminate GlobeNewswire

Aug. 20, 2026

NurExone Announces Closing of C$1,066,078 Private Placement

Indeterminate GlobeNewswire

Aug. 20, 2026

BioSyent Declares Third Quarter 2026 Dividend

Indeterminate GlobeNewswire

Aug. 20, 2026

BioSyent Releases Financial Results for Q2 and H1 2026

Indeterminate GlobeNewswire

Aug. 20, 2026

Kratom Bird Introduces New Hang Kang Kratom Capsules in Red, Green and White Varieties

Indeterminate GlobeNewswire

Aug. 20, 2026

Aveanna Announces Launch of Secondary Offering of Common Stock

Indeterminate GlobeNewswire

Aug. 20, 2026

The Ensign Group Increases Credit Facility to $800 Million and Extends Maturity

Indeterminate GlobeNewswire

Aug. 20, 2026

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 20, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 20, 2026

iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks

Indeterminate GlobeNewswire

Aug. 20, 2026

NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE

Indeterminate GlobeNewswire

Aug. 20, 2026

Adaptin Bio Announces Opening of Enrollment in a Phase 1 Clinical Trial Evaluating Treatment of Malignant Brain Tumors with APTN-101

Indeterminate GlobeNewswire

Aug. 20, 2026

Tilray festigt seine weltweite Führungsposition bei medizinischem Cannabis durch eine erhebliche Steigerung der Produktion, um der internationalen Nachfrage gerecht zu werden

Indeterminate GlobeNewswire